A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT05357755 · COMPLETED
Trial details
- NCT number
- NCT05357755
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2023-03-23
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.